iPSC-Derived MSCs Help Neurons Recover from Injury
Author Information
Author(s): Kawatani Keiji, Omana Suarez Genesis, Perkerson Ralph B. III, Parent Ephraim E., Nambara Toshihiko, Knight Joshua A., Parsons Tammee M., Gupta Kshama, Shue Francis, Alnobani Alla, Vibhute Prasanna, Cai Hancheng, Guerrero-Cázares Hugo, Copland John A. III, Quiñones-Hinojosa Alfredo, Kanekiyo Takahisa
Primary Institution: Mayo Clinic, Jacksonville, Florida
Hypothesis
How do iPSC-derived MSCs influence the properties of iPSC-derived neurons?
Conclusion
The study shows that iPSC-derived MSCs enhance neuronal survival, growth, and metabolic activity, suggesting their potential in treating neuronal damage.
Supporting Evidence
- iMSC secretome improves neuronal survival and promotes outgrowth.
- iMSCs enhance metabolic activity in neurons, improving their function.
- Intravenous administration of iMSCs restores synaptic metabolic activity in mouse models.
- iMSC treatment boosts brain glucose metabolism after radiation-induced injury.
Takeaway
Scientists found that special cells from stem cells can help brain cells grow and heal better after being hurt.
Methodology
The study involved differentiating human iPSCs into MSCs and assessing their effects on iPSC-derived neurons in vitro and in mouse models.
Limitations
The variability in clinical trial outcomes may stem from the inherent heterogeneity of somatic MSCs.
Participant Demographics
Two healthy individuals (one female, 83 years old; one male, 73 years old) were used to generate iPSCs.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website